| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 02/24/2000 | WO1999062538A8 Alpha-keto oxadiazoles as serine protease inhibitors |
| 02/24/2000 | WO1999048868A3 Heterocyclic classes of compounds for the modulating tyrosine protein kinase |
| 02/24/2000 | DE19837638A1 New arylsulfonamides and analogs, are cannabinoid receptor agonists used e.g. for treating neurodegenerative diseases, pain, convulsions or bacterial or viral infections |
| 02/24/2000 | DE19837627A1 New aminoacid esters of arylsulfonamides are useful for e.g. treating neurodegenerative diseases, pain, convulsions or bacterial or viral infections |
| 02/24/2000 | CA2341216A1 Bipyridine manganese complexes |
| 02/24/2000 | CA2340341A1 Calcilytic compounds |
| 02/24/2000 | CA2340200A1 New pharmaceutical uses for nos inhibitors |
| 02/24/2000 | CA2340182A1 Tace inhibitors |
| 02/24/2000 | CA2340180A1 1-aryl,-3-arylmethyl-1,8-naphthyridn-2(1h)-ones |
| 02/24/2000 | CA2340068A1 Calcilytic compounds |
| 02/24/2000 | CA2340053A1 C3a receptor ligands |
| 02/24/2000 | CA2339418A1 Human chordin-related proteins and polynucleotides encoding them |
| 02/24/2000 | CA2338878A1 Integrin receptor antagonists |
| 02/24/2000 | CA2338283A1 Multivalent avb3 and metastasis-associated receptor ligands |
| 02/23/2000 | EP0980866A2 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 02/23/2000 | EP0980383A1 Pharmaceutically acceptable salts of 3-hydroxy-estr-5(10)-en-17-one 3-sulphate active as estrogens |
| 02/23/2000 | EP0980382A1 Estrogenic 19-norandrost-17-one derivatives with an aromatic b-ring |
| 02/23/2000 | EP0980374A1 Phosphodiesterase 4-inhibiting diazepinoindolones |
| 02/23/2000 | EP0980354A2 Vitamin d 3? analogs with bis c-20 side chains |
| 02/23/2000 | EP0980351A1 New benzylamine and phenylethylamine derivatives, processes for preparing the same and their use as medicaments |
| 02/23/2000 | EP0980273A1 Biodegradable osteosynthesis implant |
| 02/23/2000 | EP0980250A1 Plant extracts for the treatment of increase bone resorption |
| 02/23/2000 | CN1245490A Sulfonyl urea derivatives and their use in control of interleukin-1 activity |
| 02/22/2000 | US6028207 A tetracycline type antibiotic covalent bonded with a steroid type hormone estrogen has an osteogenesis function in addition to a bone resorption inhibition, can concentrate on the bone tissues |
| 02/22/2000 | US6028090 Adhesion receptor antagonists III |
| 02/22/2000 | US6028086 Selective inhibitors of phosphodiesterase (pde) type iv or production of tumor necrosis factor (tnf) and as such are useful treatment of asthma, arthritis, bronchitis, chronic obstructive airways disease, psoriasis, allergic rhinitis |
| 02/22/2000 | US6028074 Pyrazolo[3,4-d]pyrimidineone compounds |
| 02/22/2000 | US6028072 For treating inflammation and inflammation related disorders |
| 02/22/2000 | US6028051 Administering single dose of lysostaphin analogue and lysostaphin for treating endocarditis, bacterimia, kidney infection, lung infection, skin infection, bone infection, burn wound infections, infection of prosthetic devices |
| 02/22/2000 | US6027919 BMP-12 and BMP-13 proteins and DNA encoding them |
| 02/17/2000 | WO2000008202A2 3-methylidenyl-2-indolinone modulators of protein kinase |
| 02/17/2000 | WO2000008196A2 Urate oxidase |
| 02/17/2000 | WO2000008130A2 Method for preparing a cartilage cell suspension |
| 02/17/2000 | WO2000008024A1 Substituted imidazo[1,2a]azines as selective inhibotors of cox-2 |
| 02/17/2000 | WO2000008018A1 Benzothiepin derivatives, process for the preparation of the same and uses thereof |
| 02/17/2000 | WO2000008001A1 Substituted isoxazole as estrogen receptor modulators |
| 02/17/2000 | WO2000007996A2 Pyrazoles as estrogen receptor modulators |
| 02/17/2000 | WO2000007991A1 Amide derivatives useful as inhibitors of the production of cytokines |
| 02/17/2000 | WO2000007980A1 Amide derivatives which are useful as cytokine inhibitors |
| 02/17/2000 | WO2000007977A1 Novel phenylethylamine derivatives, a method for the production thereof and their use as medicaments |
| 02/17/2000 | WO2000007629A2 Peg-urate oxidase conjugates and use thereof |
| 02/17/2000 | WO2000007598A1 Use of a nk-1 receptor antagonist for treating or preventing abnormal bone resorption |
| 02/17/2000 | WO2000007591A1 INDOLE sPLA2 INHIBITORS |
| 02/17/2000 | WO2000007590A1 INDOLE sPLA2 INHIBITORS |
| 02/17/2000 | WO2000007569A1 Compressed compositions comprising clarified xanthan gum |
| 02/17/2000 | WO2000007544A2 Vitronectin receptor antagonists |
| 02/17/2000 | WO1999065942A8 Cyclic somatostatin analogs |
| 02/17/2000 | WO1999056784A3 Inprovements in gene therapy using compositions comprising a polynucleotide and a nuclease inhibitor or interleukin-10 |
| 02/17/2000 | WO1999055859A3 Cd40-interacting and traf-interacting proteins |
| 02/17/2000 | CA2383623A1 3-methylidenyl-2-indolinone modulators of protein kinase |
| 02/17/2000 | CA2339666A1 Vitronectin receptor antagonists |
| 02/17/2000 | CA2339662A1 Benzothiepin derivatives, their production and use |
| 02/17/2000 | CA2339187A1 Substituted imidazo¬1,2a|azines as selective inhibitors of cox-2 |
| 02/17/2000 | CA2339146A1 Use of a nk-1 receptor antagonist for treating or preventing abnormal bone resorption |
| 02/17/2000 | CA2339086A1 Dna replication- and repair-associated proteins |
| 02/17/2000 | CA2338855A1 Indole spla2 inhibitors |
| 02/17/2000 | CA2338727A1 Indole spla2 inhibitors |
| 02/17/2000 | CA2338385A1 Human receptor-associated proteins |
| 02/17/2000 | CA2338121A1 Amide derivatives useful as inhibitors of the production of cytokines |
| 02/16/2000 | EP0979289A1 Human lysophospholipase |
| 02/16/2000 | EP0979230A1 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds |
| 02/16/2000 | EP0979228A1 Novel cannabinoid receptor agonists |
| 02/16/2000 | EP0979226A1 Isoxazole derivatives |
| 02/16/2000 | EP0979099A1 Use of lactoferin in the treatment of allergen induced disorders |
| 02/16/2000 | EP0979074A1 Treatment or prevention of menopausal symptoms and osteoporosis |
| 02/16/2000 | CN1244873A Antibodies that bind to the nidogen-binding domain of laminin, their production and use |
| 02/16/2000 | CN1244867A Substitued nitrogen containing heterocycles as inhibitors of P38 protein kinase |
| 02/16/2000 | CN1244414A Immune rheumatism capsule |
| 02/16/2000 | CN1049334C New use of fatty acid medicine |
| 02/15/2000 | US6025390 Heteroaromatic pentadienoic acid derivatives useful as inhibitors of bone resorption |
| 02/15/2000 | US6025376 Chiral methylphenyloxazolidinones |
| 02/15/2000 | US6025334 Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof |
| 02/15/2000 | US6024960 Rose-hip formulations as anti-inflammatory natural medicine for alleviating/reducing symptoms associated with inflammation and arthritis |
| 02/15/2000 | US6024957 Immunomodulators and methods for the prevention and reversal of organ transplant rejection using same |
| 02/15/2000 | CA2152792C Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents |
| 02/10/2000 | WO2000006769A2 Human ccr-2 gene polymorphisms |
| 02/10/2000 | WO2000006730A2 Human cytoskeletal proteins |
| 02/10/2000 | WO2000006716A1 Growth differentiation factor-11 |
| 02/10/2000 | WO2000006709A1 Human protein kinase h2lau20 |
| 02/10/2000 | WO2000006698A1 98 human secreted proteins |
| 02/10/2000 | WO2000006604A2 Use of cd25 binding molecules in the treatment of rheumatoid arthritis or skin diseases |
| 02/10/2000 | WO2000006601A1 Isoforms of human calcium sensing receptor |
| 02/10/2000 | WO2000006589A1 Prostate derived ets factor |
| 02/10/2000 | WO2000006585A1 Medicine nitrate salts |
| 02/10/2000 | WO2000006563A1 Substituted imidazoles having cytokine inhibitory activity |
| 02/10/2000 | WO2000006561A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 02/10/2000 | WO2000006254A2 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications |
| 02/10/2000 | WO2000006195A1 Targeting pharmaceutical agents to injured tissues |
| 02/10/2000 | WO2000006187A2 Modulation of apoptosis |
| 02/10/2000 | WO2000006169A1 Integrin receptor antagonists |
| 02/10/2000 | WO2000006150A1 Use of creatine compounds for treatment of bone or cartilage cells and tissues |
| 02/10/2000 | WO2000006146A1 Substituted anilide compounds and methods |
| 02/10/2000 | WO2000006140A2 Use of moclobemide for treating certain phsychiatric and medical disorders |
| 02/10/2000 | WO2000006085A2 Compounds and methods |
| 02/10/2000 | WO2000006032A1 Ultrasonic enhancement of drug injection |
| 02/10/2000 | WO2000000510A8 Growth factor modulators |
| 02/10/2000 | WO1999062526A3 Use of genetically engineered antibodies to cd38 to treat multiple myeloma |
| 02/10/2000 | WO1999058674A3 Method of inhibiting osteoclast activity |
| 02/10/2000 | DE19835368C1 Verfahren zur Herstellung einer Knorpelzellsuspension A process for the preparation of a cartilage cell suspension |
| 02/10/2000 | CA2339301A1 Hdpbo81 nucleic acids and polypeptides |